PHG
Koninklijke Philips NV ADR
NYSE: PHG · HEALTHCARE · MEDICAL DEVICES
$25.58
-5.68% today
Updated 2026-04-29
Market cap
$24.33B
P/E ratio
23.47
P/S ratio
1.37x
EPS (TTM)
$1.09
Dividend yield
3.96%
52W range
$22 – $33
Volume
1.0M
Koninklijke Philips NV ADR (PHG) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+28.9%
Last 4 quarters
Revenue YoY growth
+1.1%
Most recent quarter
EPS YoY growth
+40.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.2%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+8.3%
2026-02-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-10 | $0.71 | +33.1% | $29.62 | $32.07 | +8.3% |
| 2025-11-04 | $0.36 | -2.6% | $27.21 | $28.07 | +3.2% |
| 2025-07-28 | $0.28 | -10.3% | $26.16 | $28.02 | +7.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.54 | $0.71 | +33.1% | $5.10B | +1.1% |
| 2025-09-30 | $0.37 | $0.36 | -2.6% | $4.30B | -1.7% |
| 2025-06-30 | $0.32 | $0.28 | -10.3% | $4.34B | -2.8% |
| 2025-03-31 | $0.14 | $0.28 | +95.4% | $4.10B | -1.0% |
| 2024-12-31 | $0.60 | $0.51 | -15.0% | $5.04B | -0.4% |
| 2024-09-30 | $0.35 | $0.32 | -8.6% | $4.38B | -2.1% |
| 2024-06-30 | $0.25 | $0.30 | +20.0% | $4.46B | -0.2% |
| 2024-03-31 | $0.26 | $0.26 | +0.0% | $4.14B | -0.7% |
| 2023-12-31 | $0.57 | $0.41 | -28.1% | $5.06B | — |
| 2023-09-30 | $0.32 | $0.33 | +3.1% | $4.47B | — |
| 2023-06-30 | $0.30 | $0.28 | -6.7% | $4.47B | — |
| 2023-03-31 | $0.14 | $0.22 | +57.1% | $4.17B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $1.53 | $18.3B | +2.8% | 23 | high |
| 2027 (E) | $1.73 | $19.1B | +4.4% | 23 | high |
| 2028 (E) | $1.92 | $20.1B | +4.8% | 23 | medium |
| 2029 (E) | $2.15 | $21.1B | +5.4% | 23 | medium |
| 2030 (E) | $2.39 | $22.3B | +5.4% | 23 | medium |
Frequently asked questions
Has Koninklijke Philips NV ADR beaten earnings estimates?
Koninklijke Philips NV ADR has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +28.9% over the last 4 quarters.
How does PHG stock react to earnings?
PHG stock has moved an average of +6.2% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Koninklijke Philips NV ADR's revenue growth rate?
Koninklijke Philips NV ADR reported year-over-year revenue growth of +1.1% in its most recent quarter, with EPS growing +40.0% year-over-year.
What is the expected EPS for PHG in 2026?
Analysts expect Koninklijke Philips NV ADR to report EPS of $1.53 for fiscal year 2026, on revenue of $18.3B, based on estimates from 23 analysts.